Nicholas Antos

510 total citations
19 papers, 210 citations indexed

About

Nicholas Antos is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Speech and Hearing. According to data from OpenAlex, Nicholas Antos has authored 19 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Speech and Hearing. Recurrent topics in Nicholas Antos's work include Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (5 papers). Nicholas Antos is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (5 papers). Nicholas Antos collaborates with scholars based in United States. Nicholas Antos's co-authors include Sujani Kakumanu, Stanley J. Szefler, Robert F. Lemanske, Michelle M. Cloutier, Wanda Phipatanakul, Shirley Schantz, Philip M. Farrell, Michael J. Rock, Paul V. Williams and Sonya L. Heltshe and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Pediatric Gastroenterology and Nutrition and BMJ Quality & Safety.

In The Last Decade

Nicholas Antos

14 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Antos United States 8 131 62 58 47 23 19 210
Zhe Hui Hoo United Kingdom 11 227 1.7× 42 0.7× 37 0.6× 41 0.9× 19 0.8× 37 287
Karen Nielsen United States 3 128 1.0× 20 0.3× 166 2.9× 34 0.7× 15 0.7× 3 227
C.A. Díaz Vázquez Spain 8 101 0.8× 23 0.4× 183 3.2× 36 0.8× 22 1.0× 23 300
G. Sawicki United States 8 184 1.4× 27 0.4× 17 0.3× 20 0.4× 22 1.0× 34 231
Leila Qizalbash United Kingdom 10 54 0.4× 36 0.6× 32 0.6× 27 0.6× 107 4.7× 12 277
Fernanda Maria Vendrusculo Brazil 9 219 1.7× 22 0.4× 103 1.8× 17 0.4× 22 1.0× 35 284
E. Hallner Sweden 8 85 0.6× 56 0.9× 232 4.0× 31 0.7× 30 1.3× 9 392
Bruna Ziegler Brazil 11 248 1.9× 37 0.6× 74 1.3× 9 0.2× 20 0.9× 44 302
Pascual Chiarella Peru 5 170 1.3× 29 0.5× 180 3.1× 25 0.5× 21 0.9× 12 265
Yousser Mohammad Syria 7 72 0.5× 19 0.3× 77 1.3× 12 0.3× 7 0.3× 16 153

Countries citing papers authored by Nicholas Antos

Since Specialization
Citations

This map shows the geographic impact of Nicholas Antos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Antos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Antos more than expected).

Fields of papers citing papers by Nicholas Antos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Antos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Antos. The network helps show where Nicholas Antos may publish in the future.

Co-authorship network of co-authors of Nicholas Antos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Antos. A scholar is included among the top collaborators of Nicholas Antos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Antos. Nicholas Antos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Albon, Dana, Thida Ong, Bethany J. Horton, et al.. (2025). Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric Pulmonology. 60(5). e71102–e71102.
2.
Lai, HuiChuan J., Katryn N. Furuya, Nicholas Antos, et al.. (2025). The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis. Pediatric Pulmonology. 60(3). e71042–e71042.
3.
Carroll, Brian J., et al.. (2024). Clinical outcomes at 9–10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome. Pediatric Pulmonology. 59(6). 1606–1613. 1 indexed citations
4.
Liu, Xiaoyue Cathy, Philip M. Farrell, Derek M. Pavelec, et al.. (2024). Impact of acid blocker therapy on growth, gut microbiome, and lung disease in young children with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 79(6). 1124–1133. 2 indexed citations
5.
Antos, Nicholas, et al.. (2023). Implementing an Electronic Asthma Management Plan with School Form to Increase School Form Usage. Journal of Allergy and Clinical Immunology. 151(2). AB164–AB164.
6.
Antos, Nicholas, et al.. (2023). A Cross‐Sectional Study of Pediatric Feeding Disorder in Children with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 77(6). 819–823.
7.
Lai, HuiChuan J., Nicholas Antos, Michael J. Rock, et al.. (2022). Defining and identifying early‐onset lung disease in cystic fibrosis with cumulative clinical characteristics. Pediatric Pulmonology. 57(10). 2363–2373. 9 indexed citations
8.
Rock, Michael J., Mei Baker, Nicholas Antos, & Philip M. Farrell. (2022). Refinement of newborn screening for cystic fibrosis with next generation sequencing. Pediatric Pulmonology. 58(3). 778–787. 17 indexed citations
9.
Antos, Nicholas, Nina T. Harawa, Kayo Fujimoto, et al.. (2022). Factors associated with HIV testing and treatment among young Black MSM and trans women in three jail systems. AIDS Care. 35(1). 123–130. 1 indexed citations
10.
Antos, Nicholas & Adrienne P. Savant. (2021). Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation. Pediatric Pulmonology. 57(2). 347–360. 3 indexed citations
11.
Malin, Kathryn J., et al.. (2021). Quality Improvement Approach to Reducing Admission Hypothermia Among Preterm and Term Infants. Hospital Pediatrics. 11(3). 270–276. 9 indexed citations
12.
Moheet, Amir, Daniel Beisang, Lin Zhang, et al.. (2020). Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients. Journal of Cystic Fibrosis. 20(2). 333–338. 46 indexed citations
13.
Antos, Nicholas, et al.. (2020). Using the Electronic Health Record and a School-based Education Program to Increase Asthma Management Plan Creation. Journal of Allergy and Clinical Immunology. 145(2). AB168–AB168.
14.
Antos, Nicholas, et al.. (2019). Oral health of cystic fibrosis patients at a north american center: A pilot study. Medicina oral, patología oral y cirugía bucal. 24(3). e379–e384. 14 indexed citations
15.
Antos, Nicholas, et al.. (2019). Lactation Consultation Sustains Breast Milk Intake in Infants With Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 69(3). 358–362. 5 indexed citations
16.
Antos, Nicholas, et al.. (2019). Feasibility of a Group Telepsychological Intervention for Adolescents with Cystic Fibrosis. Journal of Technology in Behavioral Science. 5(1). 47–50. 2 indexed citations
17.
Kakumanu, Sujani, Nicholas Antos, Stanley J. Szefler, & Robert F. Lemanske. (2017). Building school health partnerships to improve pediatric asthma care: the School-based Asthma Management Program. Current Opinion in Allergy and Clinical Immunology. 17(2). 160–166. 21 indexed citations
18.
Lemanske, Robert F., Sujani Kakumanu, Nicholas Antos, et al.. (2016). Creation and implementation of SAMPRO™: A school-based asthma management program. Journal of Allergy and Clinical Immunology. 138(3). 711–723. 71 indexed citations
19.
Antos, Nicholas, et al.. (2014). Improving inpatient cystic fibrosis pulmonary exacerbation care: two success stories. BMJ Quality & Safety. 23(Suppl 1). i33–i41. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Hui Hoo Breakdown of academic impact, for papers by Karen Nielsen Breakdown of academic impact, for papers by C.A. Díaz Vázquez Breakdown of academic impact, for papers by G. Sawicki Breakdown of academic impact, for papers by Leila Qizalbash Breakdown of academic impact, for papers by Fernanda Maria Vendrusculo Breakdown of academic impact, for papers by E. Hallner Breakdown of academic impact, for papers by Bruna Ziegler Breakdown of academic impact, for papers by Pascual Chiarella Breakdown of academic impact, for papers by Yousser Mohammad
Rankless by CCL
2026